Dashboard
Manage Tickers

ADVM


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-adverum-biotechnologies-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Adve...
09/23/2025 10:53:59

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/22/2025 17:06:11

adverum-biotechnologies-says-screening-for-pivotal-phase-3-artemis-trial-of-ixo-vec-closing-ahead-of-expectations-readout-accelerated-to-q1-2027
Adverum Biotechnologies Says Screening For...
09/22/2025 12:09:57

chardan-capital-maintains-buy-on-adverum-biotechnologies-maintains-33-price-target
Chardan Capital Maintains Buy on Adverum B...
08/13/2025 14:26:04

Chardan Capital analyst Daniil Gataulin maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $33 price t...

adverum-biotechnologies-q2-eps-234-misses-221-estimate
Adverum Biotechnologies Q2 EPS $(2.34) Mis...
08/12/2025 11:09:44

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(2.34) per share which missed the analyst consensus estimat...

mizuho-maintains-outperform-on-adverum-biotechnologies-lowers-price-target-to-12
Mizuho Maintains Outperform on Adverum Bio...
06/26/2025 14:59:15

Mizuho analyst Graig Suvannavejh maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Outperform and lowers the price targ...

rbc-capital-maintains-sector-perform-on-adverum-biotechnologies-lowers-price-target-to-4
RBC Capital Maintains Sector Perform on Ad...
05/15/2025 15:55:51

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Sector Perform and lowers the price tar...

chardan-capital-maintains-buy-on-adverum-biotechnologies-maintains-33-price-target
Chardan Capital Maintains Buy on Adverum B...
05/15/2025 15:33:24

Chardan Capital analyst Daniil Gataulin maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $33 price t...

hc-wainwright--co-reiterates-buy-on-adverum-biotechnologies-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Adve...
05/15/2025 11:01:51

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

adverum-biotechnologies-q1-eps-225-misses-194-estimate
Adverum Biotechnologies Q1 EPS $(2.25) Mis...
05/14/2025 21:43:22

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(2.25) per share which missed the analyst consensus estimat...

intuit-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday
Intuit To Rally Around 19%? Here Are 10 To...
04/17/2025 12:49:11

chardan-capital-maintains-buy-on-adverum-biotechnologies-lowers-price-target-to-33
Chardan Capital Maintains Buy on Adverum B...
04/17/2025 11:38:22

Chardan Capital analyst Daniil Gataulin maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and lowers the price targ...

rbc-capital-maintains-sector-perform-on-adverum-biotechnologies-lowers-price-target-to-5
RBC Capital Maintains Sector Perform on Ad...
04/16/2025 15:19:04

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Sector Perform and lowers the price tar...

hc-wainwright--co-reiterates-buy-on-adverum-biotechnologies-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Adve...
04/16/2025 11:01:24

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

adverum-biotechnologies-q4-eps-196-misses-138-estimate
Adverum Biotechnologies Q4 EPS $(1.96) Mis...
04/15/2025 11:43:33

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(1.96) per share which missed the analyst consensus estimat...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/09/2025 12:07:29

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/31/2025 21:05:46

adverum-biotechnologies-initiates-artemis-phase-3-study-evaluating-ixo-vec-for-wet-amd
Adverum Biotechnologies Initiates ARTEMIS ...
03/03/2025 21:02:38

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequen...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/05/2024 21:05:47

hc-wainwright--co-reiterates-buy-on-adverum-biotechnologies-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Adve...
11/19/2024 09:34:36

HC Wainwright & Co. analyst Matthew Caufield reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION